ARNI treatment attenuated structural changes in terms of myocardial hypertrophy and fibrosis after myocardial infarction [33,34] and in salt-induced heart damage in rats [35], and reduced cardiomyocyte hypertrophy in Ang II-induced hypertension [36]. This evidence concerns the gene AGT and cardiac hypertrophy.